Storytel AB Vs. Sarepta Therapeutics Industry Stock Comparison

Buy

51

STRYF
Storytel AB

Last Price:

$5.68

Seasonality Move:

-2.91%

Sell

41

SRPT
Sarepta Therapeutics

Last Price:

$107.93

Seasonality Move:

1.75%

Buy

51

Storytel AB (STRYF) is a Buy

Is Storytel AB a Buy, Sell or Hold?

The current Storytel AB [STRYF] share price is $5.68. The Score for STRYF is 51, which is 2% above its historic median score of 50, and infers lower risk than normal.
STRYF is currently trading in the 50-60% percentile range relative to its historical Stock Score levels.
This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.

Sell

41

Sarepta Therapeutics (SRPT) is a Sell

Is Sarepta Therapeutics a Buy, Sell or Hold?

The current Sarepta Therapeutics [SRPT] share price is $107.95. The Score for SRPT is 41, which is 18% below its historic median score of 50, and infers higher risk than normal.
SRPT is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.

STRYF Stock Price Chart

What is Storytel AB's stock price today?

The Storytel AB share price today is $5.68

The current trend is relatively stagnant and STRYF is experiencing slight buying pressure.

SRPT Stock Price Chart

What is Sarepta Therapeutics's stock price today?

The Sarepta Therapeutics share price today is $107.95

Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and SRPT is experiencing selling pressure, which indicates risk of future bearish movement.

STRYF Technical Analysis

Chart Indicators	Level	Buy or Sell
MACD (12, 26):	0.03	Buy
Relative Strength Index (14 RSI):	100	Buy
Chaikin Money Flow:	0	-

Bollinger Bands	Level	Buy or Sell
Bollinger Bands (25):	(5.68 - 5.68)	Sell
Bollinger Bands (100):	(5.11 - 5.59)	Buy

SRPT Technical Analysis

Chart Indicators	Level	Buy or Sell
MACD (12, 26):	-2.94	Sell
Relative Strength Index (14 RSI):	33.84	Sell
Chaikin Money Flow:	-502758	-

Bollinger Bands	Level	Buy or Sell
Bollinger Bands (25):	(111.52 - 119.16)	Sell
Bollinger Bands (100):	(114.38 - 127.78)	Sell

STRYF Moving Averages

Moving Averages	Level	Buy or Sell
8-day SMA:	5.68	Sell
20-day SMA:	5.68	Sell
50-day SMA:	5.54	Buy
200-day SMA:	5.26	Buy
8-day EMA:	5.68	Buy
20-day EMA:	5.67	Buy
50-day EMA:	5.56	Buy
200-day EMA:	6.49	Sell

SRPT Moving Averages

Moving Averages	Level	Buy or Sell
8-day SMA:	111.57	Sell
20-day SMA:	114.25	Sell
50-day SMA:	119.8	Sell
200-day SMA:	128.55	Sell
8-day EMA:	110.88	Sell
20-day EMA:	113.91	Sell
50-day EMA:	117.81	Sell
200-day EMA:	123.39	Sell

Storytel AB Earnings Growth & STRYF Earnings Dates

Analysts estimate an earnings decrease this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.00 per share, and a decrease next year of $0.00 per share.

Sarepta Therapeutics Earnings Growth & SRPT Earnings Dates

Analysts estimate an earnings increase this quarter of $2.70 per share, a decrease next quarter of $0.00 per share, an increase this year of $7.63 per share, and an increase next year of $4.84 per share.

Storytel AB Technical Analysis

	Feb 3	Feb 4	Feb 5	Feb 6	Feb 7	Feb 10	Feb 11	Feb 12	Feb 13	Feb 14
	Feb
	03	04	05	06	07	10	11	12	13	14
Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):

Sarepta Therapeutics Technical Analysis

	Feb 3	Feb 4	Feb 5	Feb 6	Feb 7	Feb 10	Feb 11	Feb 12	Feb 13	Feb 14
	Feb
	03	04	05	06	07	10	11	12	13	14
Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):